SNM Annual Meeting Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     




J Nucl Med. 2008; 49 (Supplement 1):44P
This Article
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Bading, J.
Right arrow Articles by Shively, J.
PubMed
Right arrow Articles by Bading, J.
Right arrow Articles by Shively, J.

Radiopharmaceutical Chemistry: New Chemistry-Other

Novel Radio-metal Chemistry

64Cu-AMD3100: A potential radiotracer for in vivo visualization of the chemokine receptor CXCR4

James Bading1, David Colcher1, Andrew Raubitschek1 and John Shively1

1 Radioimmunotherapy, City of Hope, Duarte, California

176

Objectives: The CXCR4 receptor is highly expressed on certain types of white blood cells (WBC) and hematopoietic stem cells (HSC), providing a homing mechanism for such cells to tissues and organs that excrete the chemokine CXCL12. CXCR4/CXCL12 also has a central role in tumor metastasis. We labeled the CXCR4 antagonist AMD3100 (mol wt 794) with 64Cu and used it for in vivo imaging and biodistribution measurements in mice.

Methods: AMD3100 in ammonium acetate was added to 64Cu copper chloride and incubated at 37oC for 30 min, after which non-radioactive copper (2:1 molar ratio) was added. Reverse-phase chromatography (C18 column) demonstrated a single radioactive peak eluting at the same time as [Cu2]AMD3100. Immune-competent C57Bl mice were injected i.v. with either 0.06 ("low-dose"; n=2) or 0.46 ("high-dose"; n=2) µg/g of 64Cu-AMD3100 (130-180 kBq/g). Scans were acquired at 0.5, 1, 2 and 4 h using an R4 microPETTM (Siemens/CTMI), after which the mice were euthanized and biodistribution of 64Cu was measured by direct assay.

Results: Radiolabel was rapidly cleared into urine (>50% by 4 h) and liver (35-41% injected dose/g between 1 and 4 h in the low-dose group). Uptake was highest in tissues and organs known to constitutively express CXCL12 and/or harbor large concentrations of WBC or HSC, namely liver, bone, spleen, and lung. Uptake in each of these was reduced in the high-dose relative to the low-dose group, indicating a saturable uptake mechanism. Percentage of whole blood 64Cu in the cellular fraction at 4 h was also lower in the high-dose compared with the low-dose group (33±13% compared with 52±1%).

Conclusions: The bicyclam AMD3100, a natural chelating agent, is readily labeled with 64Cu. The biodistribution in immune competent mice was consistent with specific binding of the radiotracer to CXCR4.





This Article
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Bading, J.
Right arrow Articles by Shively, J.
PubMed
Right arrow Articles by Bading, J.
Right arrow Articles by Shively, J.